Nadine Tung, MD on Olaparib Monotherapy: Patients with Triple Negative Disease? #ASCO2020 #ASCO @DanaFarber @Harvard

Nadine Tung, MD on Olaparib Monotherapy: Patients with Triple Negative Disease? #ASCO2020 #ASCO @DanaFarber @Harvard

User Photo
Cancer-News

1 month
7 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Nadine Tung, MD of Dana Farber/Harvard Cancer Center @DanaFarber @Harvard discusses a phase II study of olaparib monotherapy in metastatic breast cancer patients with germline or somatic mutations in DNA damage response (DDR) pathway genes presented at this year's virtual ASCO.
Up Next Autoplay
User Photo